BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34675066)

  • 1. Risk of Liver Cirrhosis in HBV/HCV-Infected Individuals with First-Degree Relatives Who Have Liver Cancer: Development and Validation of a Simple Model.
    Liu Y; Guo LW; Xu HF; Kang RH; Zheng LY; Zhang LY; Chen Q; Sun XB; Zhang SK; Qiao YL
    Cancer Prev Res (Phila); 2022 Feb; 15(2):111-120. PubMed ID: 34675066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection.
    Liu Y; Guo LW; Xu HF; Kang RH; Zheng LY; Zhang LY; Chen Q; Sun XB; Qiao YL; Zhang SK
    Cancer Prev Res (Phila); 2022 Nov; 15(11):767-776. PubMed ID: 36083859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
    El-Serag HB; Richardson PA; Everhart JE
    Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.
    Koshiol J; Argirion I; Liu Z; Kim Lam T; O'Brien TR; Yu K; McGlynn KA; Petrick JL; Pinto L; Chen CJ; Hildesheim A; Pfeiffer RM; Lee MH; Yang HI
    Aliment Pharmacol Ther; 2021 Sep; 54(6):833-842. PubMed ID: 34286851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of liver cirrhosis over ten consecutive years in Southern China.
    Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
    World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of hepatitis B, C virus infection on renal transplantation.
    Lee WC; Shu KH; Cheng CH; Wu MJ; Chen CH; Lian JC
    Am J Nephrol; 2001; 21(4):300-6. PubMed ID: 11509802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019.
    McGee-Avila JK; Argirion I; Engels EA; O'Brien TR; Horner MJ; Qiao B; Monterosso A; Luo Q; Shiels MS
    J Natl Cancer Inst; 2024 Jan; 116(1):61-68. PubMed ID: 37610358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
    Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
    J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.